Last reviewed · How we verify
NCT06741709
A Study of Mitral Annular Disjunction in Mitral Valve Prolapse Patients and Arrhythmia Risk
trial in Mitral Valve Prolapse in 30 participants. Not yet recruiting.
30 October 2026
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 14 February 2025 |
| Primary completion | 30 October 2026 |
| Estimated completion | 30 December 2026 |
| Sites | 1 location across Egypt |
Conditions studied
- Mitral Valve Prolapse — all drugs for Mitral Valve Prolapse →
- Mitral Valve Insufficiency — all drugs for Mitral Valve Insufficiency →
Sponsor
Assiut University
Who can join
18 Months and older, any sex, with Mitral Valve Prolapse or Mitral Valve Insufficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study investigates the characteristics and prevalence of mitral annular disjunction in patients with mitral valve prolapse with severe mitral regurgitation (MR) at Assiut University Heart Hospital.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06741709
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mitral Valve Prolapse
Currently open trials in the same condition.
- NCT07366723 — The Role of cardIac magNeTic rEsonance in surGical Decision Making in Patients With Severe pRimAry miTral rEgurgitation · NA · active not recruiting
- NCT06255457 — Ventricular Arrhythmias in Patients Undergoing Mitral Valve Surgery · recruiting
- NCT07103733 — PRIMARY Ancillary Substudy · NA · recruiting
- NCT06738537 — Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse · recruiting
- NCT06341166 — Multiparametric SCores for Prediction of Myocardial fIbrosis in Patients With MITral vAlve pRolapse · recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06741709 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 19 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06741709.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing